Skip to main content
Top
Published in: Drugs & Aging 6/2022

15-06-2022 | Hypotension | Original Research Article

Hypotension Under Antihypertensive Treatment and Incident Hospitalizations of Nursing Home Residents

Authors: Gülistan Bahat, Birkan İlhan, Asli Tufan, Cihan Kılıç, Mehmet Akif Karan, Mirko Petrovic

Published in: Drugs & Aging | Issue 6/2022

Login to get access

Abstract

Background and Objective

Hypertension is the most prevalent chronic disease in older adults. Antihypertensive drug use increases with aging. In some studies, hypotension developing under antihypertensive medication use has been indicated as a potential risk factor for morbidity and mortality in older adults. Our objective was to assess the relationship between hypotension under antihypertensive treatment and incident hospitalization of nursing home residents.

Methods

We detailed blood pressure measurements of the previous 1-year period that were noted regularly at 2-week intervals and studied their mean values. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) thresholds to define low SBP (≤ 110 mm Hg) and DBP (≤ 65 mm Hg) were derived from our previous study. We noted demographics, number of co-morbidities and regular medications, mobility status, and nutritional assessment via the Mini Nutritional Assessment Short Form.

Results

We included 253 participants (66% male, mean age 75.7 ± 8.7 years). The prevalence of low SBP (≤ 110 mmHg) and low DBP (≤ 65 mmHg) was 34.8% and 15.8%, respectively. Among residents, 4% were bedridden, 15.8% wheelchair bound, 14.5% needing assistance for reduced mobility, and 62.7% were ambulatory. At a median of 15 months of follow-up, hospitalization incidence from any cause was 50.8% (n = 134). Incident hospitalization was more common in the group that had low DBP (odds ratio = 3.06; 95% confidence interval 1.02–9.15; p = 0.04) after adjusting for age, number of comorbidities and medications, mobility status, and nutritional status. Low SBP was not associated with hospitalization.

Conclusions

The low DBP (≤ 65 mm Hg) during the previous year was associated with incident hospitalization of nursing home residents after adjustment for several factors. These findings indicate that lower DBP may be a causative factor for incident hospitalization. We need further studies to explore whether a correction of diastolic hypotension may decrease the hospitalization risk in this vulnerable population.
Literature
1.
go back to reference Bahat G, Tufan F, Bahat Z, et al. Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. Aging Male. 2013;16(2):67–72.CrossRef Bahat G, Tufan F, Bahat Z, et al. Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. Aging Male. 2013;16(2):67–72.CrossRef
2.
go back to reference Bahat G, Tufan F, Bahat Z, et al. Comorbidities, polypharmacy, functionality and nutritional status in Turkish community-dwelling female elderly. Aging Clin Exp Res. 2014;26(3):255–9.CrossRef Bahat G, Tufan F, Bahat Z, et al. Comorbidities, polypharmacy, functionality and nutritional status in Turkish community-dwelling female elderly. Aging Clin Exp Res. 2014;26(3):255–9.CrossRef
3.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.
4.
go back to reference Briasoulis A, Agarwal V, Tousoulis D, Stefanadis C. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart. 2014;100(4):317–23.CrossRef Briasoulis A, Agarwal V, Tousoulis D, Stefanadis C. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart. 2014;100(4):317–23.CrossRef
5.
go back to reference Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–82.CrossRef Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–82.CrossRef
6.
go back to reference Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. J Geront A Biol Sci Med Sci. 2015;70(8):989–95.CrossRef Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. J Geront A Biol Sci Med Sci. 2015;70(8):989–95.CrossRef
7.
go back to reference Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.CrossRef Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.CrossRef
8.
go back to reference Bahat G, Tufan A, Karan MA. Under-representation of frail or medically compromised hypertensive older people. Heart. 2014;100(11):894.CrossRef Bahat G, Tufan A, Karan MA. Under-representation of frail or medically compromised hypertensive older people. Heart. 2014;100(11):894.CrossRef
9.
go back to reference Peralta CA, Katz R, Newman AB, Psaty BM, Odden MC. Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study. Hypertension. 2014;64(3):472–80.CrossRef Peralta CA, Katz R, Newman AB, Psaty BM, Odden MC. Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study. Hypertension. 2014;64(3):472–80.CrossRef
10.
go back to reference Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med. 2012;172(15):1162–8.CrossRef Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med. 2012;172(15):1162–8.CrossRef
11.
go back to reference Odden MC, Covinsky KE, Neuhaus JM, Mayeda ER, Peralta CA, Haan MN. The association of blood pressure and mortality differs by self-reported walking speed in older Latinos. J Gerontol A Biol Sci Med Sci. 2012;67(9):977–83.CrossRef Odden MC, Covinsky KE, Neuhaus JM, Mayeda ER, Peralta CA, Haan MN. The association of blood pressure and mortality differs by self-reported walking speed in older Latinos. J Gerontol A Biol Sci Med Sci. 2012;67(9):977–83.CrossRef
12.
go back to reference Tinetti ME, Han L, Lee DS, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.CrossRef Tinetti ME, Han L, Lee DS, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.CrossRef
13.
go back to reference Charlesworth CJ, Peralta CA, Odden MC. Functional status and antihypertensive therapy in older adults: a new perspective on old data. Am J Hypertens. 2016;29(6):690–5.CrossRef Charlesworth CJ, Peralta CA, Odden MC. Functional status and antihypertensive therapy in older adults: a new perspective on old data. Am J Hypertens. 2016;29(6):690–5.CrossRef
14.
go back to reference Gutierrez-Misis A, Sanchez-Santos MT, Banegas JR, Castell MV, Gonzalez-Montalvo JI, Otero A. Walking speed and high blood pressure mortality risk in a Spanish elderly population. J Hum Hypertens. 2015;29(9):566–72.CrossRef Gutierrez-Misis A, Sanchez-Santos MT, Banegas JR, Castell MV, Gonzalez-Montalvo JI, Otero A. Walking speed and high blood pressure mortality risk in a Spanish elderly population. J Hum Hypertens. 2015;29(9):566–72.CrossRef
15.
go back to reference Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef
16.
go back to reference Bahat G, İlhan B, Tufan A, Karan MA. Blood pressure goals in functionally limited elderly patients. Am J Med. 2017;130(7):e319–20.CrossRef Bahat G, İlhan B, Tufan A, Karan MA. Blood pressure goals in functionally limited elderly patients. Am J Med. 2017;130(7):e319–20.CrossRef
17.
go back to reference Bahat G, Ilhan B, Tufan A, Karan MA. Intensive blood pressure treatment in adults aged 60 years or older. Ann Intern Med. 2017;167(4):288.CrossRef Bahat G, Ilhan B, Tufan A, Karan MA. Intensive blood pressure treatment in adults aged 60 years or older. Ann Intern Med. 2017;167(4):288.CrossRef
18.
go back to reference Bahat G, Ilhan B, Tufan A, et al. Hypotension in nursing home residents on antihypertensive treatment: is it associated with mortality? J Am Med Dir Assoc. 2021;22(11):2319-24.e4.CrossRef Bahat G, Ilhan B, Tufan A, et al. Hypotension in nursing home residents on antihypertensive treatment: is it associated with mortality? J Am Med Dir Assoc. 2021;22(11):2319-24.e4.CrossRef
19.
go back to reference Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015;175(6):989–95.CrossRef Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015;175(6):989–95.CrossRef
20.
go back to reference Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124(7):1045–60.CrossRef Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124(7):1045–60.CrossRef
21.
go back to reference Boockvar KS, Song W, Lee S, Intrator O. Hypertension treatment in US long-term nursing home residents with and without dementia. J Am Geriatr Soc. 2019;67(10):2058–64.CrossRef Boockvar KS, Song W, Lee S, Intrator O. Hypertension treatment in US long-term nursing home residents with and without dementia. J Am Geriatr Soc. 2019;67(10):2058–64.CrossRef
22.
go back to reference Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185–91.CrossRef Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185–91.CrossRef
23.
go back to reference Kojima G, Liljas AEM, Iliffe S. Frailty syndrome: implications and challenges for health care policy. Risk Manag Healthc Policy. 2019;12:23–30.CrossRef Kojima G, Liljas AEM, Iliffe S. Frailty syndrome: implications and challenges for health care policy. Risk Manag Healthc Policy. 2019;12:23–30.CrossRef
24.
go back to reference Benetos A, Bulpitt CJ, Petrovic M, et al. An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the management of hypertension in very old, frail subjects. Hypertension. 2016;67(5):820–5.CrossRef Benetos A, Bulpitt CJ, Petrovic M, et al. An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the management of hypertension in very old, frail subjects. Hypertension. 2016;67(5):820–5.CrossRef
25.
go back to reference Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138(17):e426–83.PubMed Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138(17):e426–83.PubMed
26.
go back to reference Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRef Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRef
27.
go back to reference Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13(1):78.CrossRef Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13(1):78.CrossRef
28.
go back to reference Cesari M, Gambassi G, Abellan van Kan G, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2013;43(1):10–2.CrossRef Cesari M, Gambassi G, Abellan van Kan G, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2013;43(1):10–2.CrossRef
29.
go back to reference Streit S, Poortvliet RKE, Gussekloo J. Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old: data from the Leiden 85-plus Study. Age Ageing. 2018;47(4):545–50.CrossRef Streit S, Poortvliet RKE, Gussekloo J. Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old: data from the Leiden 85-plus Study. Age Ageing. 2018;47(4):545–50.CrossRef
30.
go back to reference Anderson TS, Jing B, Auerbach A, et al. Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge. JAMA Intern Med. 2019;179(11):1528–36.CrossRef Anderson TS, Jing B, Auerbach A, et al. Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge. JAMA Intern Med. 2019;179(11):1528–36.CrossRef
31.
go back to reference Albasri A, Hattle M, Koshiaris C, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372: n189.CrossRef Albasri A, Hattle M, Koshiaris C, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372: n189.CrossRef
32.
go back to reference Vu M, Schleiden LJ, Harlan ML, Thorpe CT. Hypertension management in nursing homes: review of evidence and considerations for care. Curr Hypertens Rep. 2020;22(1):8.CrossRef Vu M, Schleiden LJ, Harlan ML, Thorpe CT. Hypertension management in nursing homes: review of evidence and considerations for care. Curr Hypertens Rep. 2020;22(1):8.CrossRef
33.
go back to reference Mangin D, Bahat G, Golomb BA, Mallery LH, Moorhouse P, Onder G, et al. International Group for Reducing Inappropriate Medication Use and Polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018;35:575–87.CrossRef Mangin D, Bahat G, Golomb BA, Mallery LH, Moorhouse P, Onder G, et al. International Group for Reducing Inappropriate Medication Use and Polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018;35:575–87.CrossRef
34.
go back to reference Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6:212–33.CrossRef Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6:212–33.CrossRef
35.
go back to reference Benetos A. How to obtain more evidence for the management of hypertension in frail patients over 80 years old? Eur Geriatr Med. 2018;9:137–40.CrossRef Benetos A. How to obtain more evidence for the management of hypertension in frail patients over 80 years old? Eur Geriatr Med. 2018;9:137–40.CrossRef
Metadata
Title
Hypotension Under Antihypertensive Treatment and Incident Hospitalizations of Nursing Home Residents
Authors
Gülistan Bahat
Birkan İlhan
Asli Tufan
Cihan Kılıç
Mehmet Akif Karan
Mirko Petrovic
Publication date
15-06-2022
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 6/2022
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-022-00951-0

Other articles of this Issue 6/2022

Drugs & Aging 6/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.